Related Experiment Video

Updated: Apr 21, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

36.2K

Mig-6 suppresses endometrial cancer associated with Pten deficiency and ERK activation

Tae Hoon Kim1, Jung-Yoon Yoo2, Hong Im Kim1

  • 1Department of Obstetrics, Gynecology and Reproductive Biology, Michigan State University College of Human Medicine, Grand Rapids, Michigan.

Cancer Research
|November 8, 2014
PubMed

Insights

Loss of PTEN in endometrial cancer is common. New research shows MIG-6 acts as a tumor suppressor by regulating ERK1/2 phosphorylation, suggesting ERK1/2 inhibitors may treat PTEN-mutant endometrial cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • PTEN mutations are frequent in endometrial cancer, leading to AKT activation and promoting tumorigenesis.
  • The PTEN/AKT pathway's role in endometrial cancer progression is not fully understood.
  • MIG-6, a progesterone signaling mediator, functions as a tumor suppressor by inhibiting estrogen signaling.

Purpose of the Study:

  • To investigate the role of MIG-6 as a tumor suppressor in PTEN-deficient endometrial cancer.
  • To elucidate the mechanism by which MIG-6 influences endometrial cancer progression.
  • To explore the therapeutic potential of targeting the MIG-6/ERK1/2 pathway.

Main Methods:

  • Utilized transgenic mouse models with Mig-6 overexpression in progesterone receptor-expressing cells.
  • Administered ERK1/2 inhibitors to assess their effect on tumor progression in Pten-deficient mice.
  • Analyzed clinical endometrial cancer specimens to correlate MIG-6 expression with ERK1/2 phosphorylation.

Main Results:

  • Overexpression of Mig-6 reduced uterine tumorigenesis in Pten-deficient mice.
  • ERK1/2 phosphorylation was observed in uterine tumors, and its inhibition suppressed cancer progression.
  • Clinical endometrial cancer samples showed an inverse correlation between MIG-6 expression and ERK1/2 phosphorylation.

Conclusions:

  • MIG-6 acts as a tumor suppressor in PTEN-mutant endometrial cancer.
  • MIG-6 regulates ERK1/2 phosphorylation, a key factor in endometrial cancer progression.
  • Targeting ERK1/2 signaling presents a potential therapeutic strategy for PTEN-mutant endometrial cancers.

More Related Videos

Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice07:44

Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice

Published on: February 17, 2023

2.4K
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

14.9K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.3K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
25.2K